In contrast, BRAF-like mutations, including the BRAF V600E mutation, are commonly linked to more aggressive thyroid cancers, characterized by elevated MAPK signaling and a reduced sensitivity to negative feedback [9]. Here, BRAF is linked to thyroid cancer.